beta-Blocker and renal function.
作者信息
Jackson D A
出版信息
Br Med J. 1979 Apr 28;1(6171):1149. doi: 10.1136/bmj.1.6171.1149-c.
Abstract
摘要
相似文献
1
beta-Blocker and renal function.β受体阻滞剂与肾功能
Br Med J. 1979 Apr 28;1(6171):1149. doi: 10.1136/bmj.1.6171.1149-c.
2
Effects of Kö 1366 on the distribution of intrarenal blood flow in normal canine kidneys.Kö 1366对正常犬肾肾内血流分布的影响。
Arzneimittelforschung. 1974 Sep;24(9):1325-8.
3
Activation of capsaicin-sensitive sensory neurons by carvedilol, a nonselective beta-blocker, in spontaneous hypertensive rats.非选择性β受体阻滞剂卡维地洛对自发性高血压大鼠辣椒素敏感感觉神经元的激活作用
J Pharmacol Exp Ther. 2004 May;309(2):684-91. doi: 10.1124/jpet.103.061150. Epub 2004 Feb 5.
4
The effect of celiprolol on peripheral circulation in healthy volunteers.塞利洛尔对健康志愿者外周循环的影响。
Br J Clin Pract Suppl. 1985 Jun;40:91-9.
5
Effect of carvedilol on ambulatory blood pressure, renal hemodynamics, and cardiac function in essential hypertension.卡维地洛对原发性高血压患者动态血压、肾血流动力学及心功能的影响
J Cardiovasc Pharmacol. 1987;10 Suppl 11:S130-6.
6
[Tertatolol--characteristics of the drug].[特他洛尔——药物特性]
Wiad Lek. 1992 Mar;45(5-6):196, 200, 204 passim.
7
Letter: Beta receptors and renin release.信件：β受体与肾素释放
N Engl J Med. 1974 Jan 31;290(5):284. doi: 10.1056/NEJM197401312900516.
8
Effect of some beta-adrenergic blocking drugs on the renal bloow flow in dogs.某些β-肾上腺素能阻断药物对犬肾血流量的影响。
Arch Int Pharmacodyn Ther. 1977 Oct;229(2):227-34.
9
Recent advances in beta blockade. Therapeutic implications in hypertension. Proceedings of the First International Symposium on Tertatolol, 15th June, 1985, Milano, Italy.β受体阻滞剂的最新进展。对高血压的治疗意义。1985年6月15日于意大利米兰召开的第一次国际替他洛尔研讨会会议记录
Am J Nephrol. 1986;6 Suppl 2:1-116. doi: 10.1159/000167323.
10
Some aspects of kidney function, the renin-aldosterone system and sympathetic activity in essential hypertension.
Acta Med Scand Suppl. 1980;636:1-66.
本文引用的文献
1
beta-adrenergic blockade in essential hypertension: reduced renin release despite renal vasoconstriction.原发性高血压中的β-肾上腺素能阻滞剂：尽管存在肾血管收缩，但肾素释放减少。
Circ Res. 1976 Oct;39(4):532-6. doi: 10.1161/01.res.39.4.532.
2
Dose-ranging study of the new beta-adrenergic antagonist nadolol in the treatment of essential hypertension.
Curr Med Res Opin. 1978;5(5):383-7. doi: 10.1185/03007997809111902.
Zotero 插件